1. Home
  2. LEXX vs OPHC Comparison

LEXX vs OPHC Comparison

Compare LEXX & OPHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEXX
  • OPHC
  • Stock Information
  • Founded
  • LEXX 2004
  • OPHC 2000
  • Country
  • LEXX Canada
  • OPHC United States
  • Employees
  • LEXX N/A
  • OPHC N/A
  • Industry
  • LEXX Biotechnology: Pharmaceutical Preparations
  • OPHC Major Banks
  • Sector
  • LEXX Health Care
  • OPHC Finance
  • Exchange
  • LEXX Nasdaq
  • OPHC Nasdaq
  • Market Cap
  • LEXX 19.6M
  • OPHC 51.8M
  • IPO Year
  • LEXX N/A
  • OPHC N/A
  • Fundamental
  • Price
  • LEXX $0.90
  • OPHC $4.56
  • Analyst Decision
  • LEXX Strong Buy
  • OPHC
  • Analyst Count
  • LEXX 1
  • OPHC 0
  • Target Price
  • LEXX $5.00
  • OPHC N/A
  • AVG Volume (30 Days)
  • LEXX 84.8K
  • OPHC 7.2K
  • Earning Date
  • LEXX 07-22-2025
  • OPHC 08-05-2025
  • Dividend Yield
  • LEXX N/A
  • OPHC N/A
  • EPS Growth
  • LEXX N/A
  • OPHC 30.24
  • EPS
  • LEXX N/A
  • OPHC 1.33
  • Revenue
  • LEXX $525,923.00
  • OPHC $39,980,000.00
  • Revenue This Year
  • LEXX $6.04
  • OPHC N/A
  • Revenue Next Year
  • LEXX $8.36
  • OPHC N/A
  • P/E Ratio
  • LEXX N/A
  • OPHC $3.42
  • Revenue Growth
  • LEXX 29.95
  • OPHC 53.28
  • 52 Week Low
  • LEXX $0.82
  • OPHC $3.53
  • 52 Week High
  • LEXX $4.38
  • OPHC $5.90
  • Technical
  • Relative Strength Index (RSI)
  • LEXX 43.04
  • OPHC 60.87
  • Support Level
  • LEXX $0.86
  • OPHC $4.51
  • Resistance Level
  • LEXX $1.05
  • OPHC $4.59
  • Average True Range (ATR)
  • LEXX 0.06
  • OPHC 0.06
  • MACD
  • LEXX 0.01
  • OPHC 0.01
  • Stochastic Oscillator
  • LEXX 35.09
  • OPHC 83.12

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.

About OPHC OptimumBank Holdings Inc.

OptimumBank Holdings Inc serves as a bank holding company for OptimumBank. The Bank provides community banking services to individuals and corporate customers. Its services include demand interest-bearing and non-interest-bearing accounts, negotiable order of withdrawal accounts, money market deposit accounts, debit cards, and automated teller machines.

Share on Social Networks: